HAVAH Therapeutics

HAVAH Therapeutics is a women’s hormonal health biopharmaceutical company. It develops hormonal therapies to help women with breast pain, menopausal symptoms, and breast cancer. HAVAH's drug candidate T+Ai is designed to reduce mammographic breast density and prevent breast cancer.